India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) meeting to discuss vaccination protocol for 5-12 year old kids remained inconclusive on Wednesday, according to sources.
The NTAGI members reviewed data from vaccine makers for 5-12 year old kids, but no decision on whether to expand the program to this younger group was taken.
Last month the regulator had approved two vaccines–Serum Institute’s Covovax and Biological E-made Corbevax–for use in 5-12-year-old children.
However the NTAGI decides on whether these would be used in India’s Covid-19 vaccination programme.
News Time 